Bird Flu > Bird Flu News > Armed Forces Institute of Pathology to Conduct NanoViricides Animal Studies against Bird Flu    (Centre Daily Times)

Armed Forces Institute of Pathology to Conduct NanoViricides Animal Studies against Bird Flu    (Centre Daily Times)
NanoViricides, Inc. (OTC BB: NNVC.OB ) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.